Radiotherapy-associated angiosarcoma (RAAS) has been reported as a rare, but serious late complication of radiotherapy (RT) for breast cancer. This study describes the incidence, latency period, and outcomes of RAAS using the prospective database from the nationwide Netherlands Cancer Registry.
Rombouts et al. (Fri,) studied this question.